Genscript Biotech saw the highest growth of 189% in patent filings in February and 99% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 166% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Genscript Biotech‘s patent filings and grants. Buy the databook here.
Genscript Biotech has been focused on protecting inventions in World Intellectual Property Organization(WIPO) with 13 publications in Q1 2024
The World Intellectual Property Organization(WIPO) Patent Office dominates the patent filings with nearly 35% of filings. The World Intellectual Property Organization(WIPO), United States(US), European Patent Office(EPO), and South Korea(KR) patent Office are among the top ten patent offices where Genscript Biotech is filings its patents. Among the top granted patent authorities, Genscript Biotech has 67% of its grants in United States(US).
F. Hoffmann-La Roche and Pfizer could be the strongest competitors for Genscript Biotech
Patents related to cell & gene therapy and immuno-oncology lead Genscript Biotech's portfolio
Genscript Biotech has the highest number of patents in cell & gene therapy followed by, immuno-oncology and climate change. For cell & gene therapy, nearly 60% of patents were filed and no patents were granted in Q1 2024.
Cell therapy related patents lead Genscript Biotech portfolio followed by human immunodeficiency virus (hiv) infections (aids), and animal feed
Genscript Biotech has highest number of patents in cell therapy followed by human immunodeficiency virus (hiv) infections (aids), animal feed, multiple myeloma (kahler disease), and peritoneal cancer.
For comprehensive analysis of Genscript Biotech's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.